6609 — Shanghai HeartCare Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$545.24m
- -HK$210.24m
- CNY232.34m
- 19
- 38
- 40
- 19
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -75.5 | -216 | -198 | -201 | -103 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 44.8 | 141 | 44.1 | 35.8 | 7.25 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.96 | -7.9 | -64.2 | -133 | -25 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -32.3 | -74.8 | -206 | -267 | -88.4 |
Capital Expenditures | -20.8 | -15.6 | -54.5 | -37.2 | -49.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -24.5 | 11.1 | -107 | 82.1 | -76.1 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -45.3 | -4.53 | -161 | 44.8 | -125 |
Financing Cash Flow Items | 95.4 | 687 | -105 | -5.29 | 0.297 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 94.5 | 686 | 821 | -24.8 | -21.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 16.9 | 607 | 454 | -247 | -234 |